ClinicalTrials.gg
Drug

Gadolinium ethoxybenzyl DTPA clinical trials

Also written Eovist, Gadoxetate disodium and ZK 139834.

studies test it
13
open now
1
in phase 3
2
first study started
2007

How each study uses gadolinium ethoxybenzyl DTPA is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the gadolinium ethoxybenzyl DTPA studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
3 Jul 2008 · EOVIST · NDA 022090 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Primovist
5
Gd-EOB-DTPA
3
Gadolinium EOB DTPA
2
Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid
2
Gd-(S)-EOB-DTPA
2

Brand

Eovist
7

Development codes

ZK 139834
2
BAY86-4873
1

Other names

Gadoxetate disodium
6
Gadoxetic Acid Disodium
2
GADOXETIC ACID
1
Gadoxetate Sodium
1

Studies by the year they started

13 studies that test it; most in 2013 (2)

Studies that test gadolinium ethoxybenzyl DTPA, by start year
YearStudies
20071
20091
20101
20121
20132
20141
20152
20171
20181
20212

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
1
Phase 2
1
Phase 3
2
Phase 4
6
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 4 · Other 9

Bayer (3) · M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1) · Duke University (1) · Sara Varea (1) · University of Southern California (1) · Guerbet (1) · University of Colorado, Denver (1)

Often tested with

Tested in the same studies.

Gadobenic acid (2) · Gadodiamide (1)

Studies

Open first, then newest update. How each study uses gadolinium ethoxybenzyl DTPA is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 13

Codes

What other systems call gadolinium ethoxybenzyl DTPA · ClinicalTrials.gg INT003622

  • MeSH (NLM) C073590gadolinium ethoxybenzyl DTPAConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 3QJA87N40SGADOXETIC ACIDConfirmed FDA, NLM
  • RxNorm 802624One source FDA

Also registered as gadoxetate disodium (UNII HOY74VZE0M · RxNorm 637320).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.